Medications - Page 5

January 12

What are GLP-3s? Meet the new generation of weight-loss drugs with three key ingredients

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the improvement of other conditions in longer studies.

January 9

Weight-loss experts predict 5 major treatment changes likely to emerge in 2026

Weight-loss experts reveal their major predictions for 2026, from advanced GLP-1 treatments to AI-driven personalized therapy and minimally invasive procedures.

January 7

Little-known prescription pill is helping Americans drink less alcohol

Struggling with alcohol cravings? Naltrexone targets the brain's reward center to minimize drinking urges and reduce harmful binge-drinking behaviors.

January 6

Common pain relievers may raise heart disease and stroke risk, doctors warn

Common OTC painkillers like ibuprofen may increase heart attack and stroke risk. Learn which medications pose the greatest cardiovascular danger.

January 5

Not all cancers should be treated right away, medical experts say — here's why

Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when "watchful waiting" may be the best approach.

January 3

Deadly 'superbug' is spreading across US as drug resistance grows, researchers warn

Researchers discovered a possible weakness in the deadly hospital superbug C. auris that could lead to new treatments for the drug-resistant fungal infection.

January 2

Experimental vaccine could save thousands of lives per year, scientist claims

The first-ever fentanyl overdose prevention vaccine could save thousands of lives annually, with human trials beginning in early 2026 after animal studies.

January 1

Oprah joins wave of celebrities who revealed dramatic weight loss in 2025

Celebrities have embraced GLP-1 medications for dramatic weight loss in 2025. Oprah Winfrey, Amy Schumer, Meghan Trainor and Lizzo share their health journeys.

December 31

Older Americans are quitting GLP-1 weight-loss drugs for 4 key reasons

Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications like Ozempic and Wegovy despite results.

December 30

Diabetes patients experience lower death rate with common medication

New research finds statins benefit adults with type 2 diabetes across all heart-risk levels, reducing deaths and serious cardiovascular events.